Evidence map›Paper›PMID 31923746›Full record

ReviewGrowth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society2020

Tissue-specific disruption of the growth hormone receptor (GHR) in mice: An update.

Silvana Duran-Ortiz, Vanessa Noboa, John J Kopchick

Open access · greenAbstract readReview
In one paragraph

Review in Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Silvana Duran-OrtizEdison Biotechnology Institute, United States of America; Department of Biological Sciences, College of Arts and Sciences, United States of America; Molecular and Cellular Biology Program, United States of America. Electronic address: sd504111@ohio.edu.
Vanessa NoboaSchool of Medicine, Universidad San Francisco de Quito, United States of America. Electronic address: vnoboa@usfq.edu.ec.
John J KopchickEdison Biotechnology Institute, United States of America; Molecular and Cellular Biology Program, United States of America; Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH 45701, United States of America. Electronic address: kopchick@ohio.edu.
Biotechnology Institute · USOhio University · USUniversity of San Francisco · US

Funding

Modulating Growth Hormone Action as a Target for Improved Health and LongevityR01AG059779 · NIA · OHIO UNIVERSITY ATHENS · PI John Joseph Kopchick · 2018 to 2026
$4.7M
NIA NIH HHS R01 AG059779
6 · The paper itself

Abstract

The Growth hormone receptor (GHR) is expressed in many cells/tissues in the body. To investigate the specific metabolic effects of GH action in distinct tissues, several tissue-specific GHR gene disrupted or knockout (KO) mouse lines have been generated. Previously, we have described the effects of GHRKO in several known insulin sensitive tissues, namely liver, muscle and adipose tissue. In this review, we further explore and summarize the main findings of recently published GHRKO results in liver, adipocytes, intestine, bone, brain and heart.

Indexed as

AdipocytesAnimalsBlood GlucoseBone and BonesBrainGene Knockout TechniquesGrowth HormoneHeartInsulinInsulin-Like Growth Factor IInsulin ResistanceIntestinal MucosaIntestinesLiverMiceMice, KnockoutBlood GlucoseGrowth HormoneInsulinInsulin-Like Growth Factor IReceptors, SomatotropinAdipose tissueBoneBrainGrowth hormone receptorHeartIGF-IIntestineLiverMacrophagesTissue-specific

Identifiers

PMID31923746
PMCPMC9704042
OpenAlexW2997727056

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.